* IRIDEX Corp IRIX.OQ IRIX.O is expected to show a rise in
quarterly revenue when it reports results on November 11.
* The Mountain View, California-based company is expected to
report a 35.2% increase in revenue to $11.905 million from $8.8
million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for IRIDEX Corp is for a
loss of 14 cents per share. For the same quarter last year, the
company reported a loss of 12 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for IRIDEX Corp is
$10.5, about 14% above its last closing price of $9.03.
This summary was machine generated November 9 at 22:15 GMT. All
figures in US dollars unless otherwise stated